Why are we optimistic about the future of cancer care?
A message from Dr. Bradly Wouters and Dr. Mary Gospodarowicz
Thanks to extraordinary advances we have made across the spectrum of cancer research, patient care and education, there are many reasons to be optimistic. Survival rates for Canadians diagnosed with cancer have climbed from 56% to 63% over the last decade. Quality of life has also improved substantially thanks to the increasing preservation of healthy tissue through targeted treatments, as well as survivorship programs and unprecedented forays into interdisciplinary psychosocial research.
We are optimistic because, at the frontiers of cancer research, we are seeing significant change.
At Princess Margaret Cancer Centre, breakthrough discovery and compassionate care go hand-in-hand. Our clinician scientists provide valuable clinical insights to our researchers, who then witness the impact of their research discoveries on patient care. It is this union between research and clinical care that makes us one of the top 5 cancer research centres in the world. Another key component of our research success is that we are Canada’s only comprehensive research and cancer treatment centre.
Because of this unique environment, The Princess Margaret continues to attract and retain outstanding talent from other leading cancer institutions around the globe. As part of University Health Network (UHN), The Princess Margaret welcomed newly appointed UHN President & CEO, Dr. Peter Pisters, at the beginning of 2015. Dr. Pisters is an internationally recognized academic surgical oncologist and was formerly Vice President, Regional Care System at University of Texas MD Anderson Cancer Center. His guidance and insight will help keep The Princess Margaret at the forefront of cancer research and cancer care.
Beyond our world-class staff, several newly established centres, collaborations and research breakthroughs are making our vision—Conquer Cancer In Our Lifetime—a reality. Over the past year, we launched the Joe Finley Centre for Head and Neck Cancer Research. We partnered with other internationally acclaimed cancer centres such as Vall d’Hebron Institute of Oncology in Barcelona, Spain and Tata Memorial Centre in Mumbai, India. By facilitating the transfer of knowledge within The Princess Margaret and on a global basis, we help ensure the highest standards of care are available to the widest range of patients.
For decades, Princess Margaret researchers have had a profound impact on the way cancer is detected, diagnosed, targeted and supported. To accommodate our growing research enterprise, we expanded our campus to include the Princess Margaret Cancer Research Tower. Advancing our knowledge, making new discoveries and translating this into the clinic to improve patient outcomes is embedded in The Princess Margaret’s DNA.
Though our work is far from over, we remain optimistic because we have the expertise to lay the groundwork for important progress in the years ahead. With the support and generosity of our extraordinary donors, we will continue to advance cancer research to improve care for patients across Canada and beyond.
Thank you for your support,
|Dr. Bradly Wouters
Science and Research, UHN
||Dr. Mary Gospodarowicz
Princess Margaret Cancer Centre/UHN